Related Experiment Videos
Explaining reduced cancer survival among the disadvantaged
H P Greenwald1, E F Borgatta, R McCorkle
1Sacramento Center, University of Southern California 95814-2919, USA. Greenwa@mizar.usc.edu
The Milbank Quarterly
|January 1, 1996
Summary
Socially disadvantaged cancer patients have higher mortality risks. While improved healthcare access can help, it won't fully equalize survival chances compared to advantaged patients.
Area of Science:
- Oncology
- Health Disparities
- Social Determinants of Health
Background:
- Socially disadvantaged cancer patients exhibit higher mortality rates than their advantaged counterparts.
- The underlying reasons for these survival disparities remain incompletely understood.
- Existing research points to intricate links between biological, medical, and social factors.
Purpose of the Study:
- To investigate the complex interrelations determining survival differences in cancer patients.
- To explore the impact of social differentiation on cancer patient outcomes.
- To evaluate the potential of improved healthcare access in mitigating survival disparities.
Main Methods:
- Analysis of a newly completed 10-year cancer survival study.
- Examination of biological factors, medical interventions, and social dimensions.
- Application of economic and cognitive-behavioral models to survival determinants.
Main Results:
- Survival differences are shaped by complex interactions of biological, medical, and social factors.
- Cancer survival patterns align with an "economic" model for some cancers and a "cognitive-behavioral" model for others.
- Improved healthcare access demonstrated a reduction in mortality risk for disadvantaged patients in certain malignancies.
Conclusions:
- While improved healthcare access is beneficial, it is insufficient to achieve equal survival outcomes for disadvantaged cancer patients.
- Addressing social determinants of health is crucial for reducing cancer mortality disparities.
- Further research is needed to fully understand and address the multifaceted nature of cancer survival inequalities.